Verve stock price remains a speculative buy for many analysts, with price targets ranging between $14 and $15 based on expected trial success and market adoption curves in genetic cardiovascular treatments. Overall VERV ranks 4th on our list of the best NASDAQ stocks under$5. While we acknowledge the potential of VERV as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than VERV but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock . AI chip firm Cerebras files to withdraw highly anticipated US listing Long-term projections for Verve stock price remain favorable, with analysts citing high-margin potential in targeted lipid-lowering therapies. The next two quarters will likely determine broader investment sentiment.